Polaris Capital Management, LLC
Source: SEC Form 13F · as of Mar 2026Polaris Capital Management, LLC holds 10 biotech & pharma companies tracked by BioSniper, totaling $268.4M in value as of Mar 2026 (SEC Form 13F).
Companies held
10
Total value held
$268.4M
| Company | Shares | Value |
|---|---|---|
| JAZZJazz Pharmaceuticals plc | 415,366 | $78.5M |
| UTHRUNITED THERAPEUTICS Corp | 96,650 | $57.3M |
| LNTHLantheus Holdings, Inc. | 617,000 | $46.8M |
| GILDGILEAD SCIENCES, INC. | 252,200 | $35.1M |
| ABBVAbbVie Inc. | 116,677 | $25.4M |
| ELVElevance Health Inc. | 71,641 | $21.0M |
| ANIPANI PHARMACEUTICALS INC | 15,600 | $1.2M |
| SUPNSUPERNUS PHARMACEUTICALS, INC. | 22,500 | $1.2M |
| HRMYHarmony Biosciences Holdings, Inc. | 36,100 | $1.0M |
| AMPHAmphastar Pharmaceuticals, Inc. | 43,232 | $847K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.